Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc. (Form: 3, Received: 12/14/2017 16:51:32)
FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Bartram Richard

2. Date of Event Requiring Statement (MM/DD/YYYY)
12/14/2017 

3. Issuer Name and Ticker or Trading Symbol

Esperion Therapeutics, Inc. [ESPR]

(Last)        (First)        (Middle)

C/O ESPERION THERAPEUTICS, INC., 3891 RANCHERO DRIVE, SUITE 150

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
Chief Financial Officer /

(Street)

ANN ARBOR, MI 48108       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   1200   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy)     (1) 4/24/2018   Common Stock   17892   $3.70   D    
Stock Option (right to buy)     (1) 7/23/2023   Common Stock   15000   $17.11   D    
Stock Option (right to buy)     (2) 12/20/2023   Common Stock   17200   $12.92   D    
Stock Option (right to buy)     (3) 1/2/2025   Common Stock   30000   $41.23   D    
Stock Option (right to buy)     (4) 3/18/2025   Common Stock   12000   $105.72   D    
Stock Option (right to buy)     (5) 1/4/2026   Common Stock   25000   $21.65   D    
Stock Option (right to buy)     (6) 1/3/2027   Common Stock   30000   $12.88   D    
Stock Option (right to buy)     (7) 2/21/2027   Common Stock   6500   $24.42   D    

Explanation of Responses:
(1)  The options are fully vested as of the date hereof.
(2)  The options vest over a four (4) year period. 25% of the shares vested on December 20, 2014, and an additional 1/16th vests on each quarterly anniversary of such date thereafter.
(3)  The options vest over a four (4) year period in equal quarterly installments, the first of which was on April 2, 2015.
(4)  The options vest over a four (4) year period in equal quarterly installments, the first of which was on June 18, 2015.
(5)  The options vest over a four (4) year period in equal quarterly installments, the first of which was on April 4, 2016.
(6)  The options vest over a four (4) year period in equal quarterly installments, the first of which was on April 3, 2017.
(7)  The options vest over a four (4) year period in equal quarterly installments, the first of which was on May 21, 2017.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Bartram Richard
C/O ESPERION THERAPEUTICS, INC.
3891 RANCHERO DRIVE, SUITE 150
ANN ARBOR, MI 48108


Chief Financial Officer

Signatures
Richard B. Bartram 12/14/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.